John A. Glaspy
University of California, Los Angeles(US)UCLA Health(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Erythropoietin and Anemia Treatment, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses
Most-Cited Works
- → PD-1 blockade induces responses by inhibiting adaptive immune resistance(2014)6,551 cited
- → Adjuvant Trastuzumab in HER2-Positive Breast Cancer(2011)2,750 cited
- → Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer(1991)1,401 cited
- → Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.(1998)1,077 cited
- → RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer(2011)1,055 cited
- → Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy